Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 181 AL 195

Testing the right target and right drug at the right stage

Sperling RA, Jack CR Jr, Aisen PS.

Sci Transl Med. 2011 Nov 30;3(111):111cm33. doi: 10.1126/scitranslmed.3002609.

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease

Cuadrado-Tejedor M, García-Osta A, Ricobaraza A, Oyarzabal J, Franco R.

Curr Med Chem. 2011;18(36):5545-53. doi: 10.2174/092986711798347315.

The beneficial role of vitamin D in Alzheimer's disease

Lu'o'ng KV, Nguyên LT.

Am J Alzheimers Dis Other Demen. 2011 Nov;26(7):511-20. doi: 10.1177/1533317511429321. Epub 2011 Dec 27.

Management of moderate to severe Alzheimer's disease: focus on memantine

Dominguez E, Chin TY, Chen CP, Wu TY.

Taiwan J Obstet Gynecol. 2011 Dec;50(4):415-23. doi: 10.1016/j.tjog.2011.10.004.

Sertraline for the treatment of depression in Alzheimer disease: genetic influences

Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D; DIADS-2 Research Group.

J Geriatr Psychiatry Neurol. 2011 Dec;24(4):222-8. doi: 10.1177/0891988711422527.

Effective pharmacological management of Alzheimer's disease

Atri A.

Am J Manag Care. 2011 Nov;17 Suppl 13:S346-55.

The costs of Alzheimer's disease and the value of effective therapies

Stefanacci RG.

Am J Manag Care. 2011 Nov;17 Suppl 13:S356-62.

[The minimum efficiency of drugs against Alzheimer's disease]

Deleuze J.

Rev Prat. 2011 Nov;61(9):1187.

[A case of severe hypokalemia caused by a Chinese herbal remedy (Yokukansan) in an 81-year-old woman with dementia]

Nishiyama N, Takeshita M, Tanaka K, Miyao M, Mizuno Y.

Nihon Ronen Igakkai Zasshi. 2011;48(5):553-7. doi: 10.3143/geriatrics.48.553.

[Effects of donepezil treatment on platelets α and β secretase activities in Alzheimer's disease patients]

Dong GS, Li X, Jiang QH, Yang HQ.

Zhonghua Yi Xue Za Zhi. 2011 Dec 20;91(47):3341-5.

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Gao C, Hölscher C, Liu Y, Li L.

Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061.

[Scope and limitation of medical treatment for Alzheimer' s disease]

Sugimoto H.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:9-15.

[Rivastigmine]

Monji A.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:36-40.

[Gamma-secretase inhibitors and modulators]

Iwai A.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:83-7.

[Beta-secretase inhibitor]

Fukumoto H.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:88-92.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias